In the News May 23, 2016

The Deal | Xenoport Gets Acquired, But Not by Big Public Pharma

Mark Ray and Sarah Ernst are mentioned for advising Arbor Pharmaceuticals in its acquisition of XenoPort for a total equity value of approximately $467 million.
Media Contact
Alex Wolfe
Communications Director

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.